中文
BioGeometry and Sino Biological Deepen Strategic Cooperation to Empower Protein R&D with GenAI
Building on the success of previous projects, the two parties aim to jointly explore high-value market opportunities.
Author: BioGeometry
BioGeometry secures Pre-A round funding to advance GenAI for biosolutions
Driving the transformation towards a digital, intelligent and sustainable future
Learn MoreBioGeometry secures Pre-A round funding to advance GenAI for biosolutions
Introducing GeoFlow: Next-Gen Generative Model for Antibody Modeling and Design
Antibody-antigen docking performance on par with AlphaFold3
Learn MoreIntroducing GeoFlow: Next-Gen Generative Model for Antibody Modeling and Design
BioGeometry Joins Hands with Sanyou to Build a New Generation AIGC-Driven Antibody Drug Discovery Platform
Both parties will create a next-generation AIGC-driven antibody drug discovery platform jointly and promote tripartite cooperation with significant innovative drug companies or biotech firms to enhance the efficiency of new drug R&D and help pharmaceutical R&D enterprises improve their global competitiveness.
BioGeometry Announces Strategic Cooperation with Symray Biopharma for the Large Molecule Drug R&D
Both parties will fully leverage their respective strengths in a comprehensive strategic collaboration within the field of large molecule pharmaceuticals, aiming to achieve breakthrough progress in antibody drug R&D through the application of AI technology.
BioGeometry and BioMetas Join Hands to Empower Development of Novel Large Molecule Drugs
The two parties will engage in deep collaboration on platform products, project optimization services, and resource expansion to promote innovation together in antibody research and development, providing pharmaceutical clients with higher-quality R&D services.
Learn MoreBioGeometry and BioMetas Join Hands to Empower Development of Novel Large Molecule Drugs
BioGeometry and Zhipu AI Establish Strategic Cooperation to Building a Large Multimodal Model between Human Language and Biological Language
Both companies are dedicated to constructing a large multimodal model（LMM）that aligns human natural language with the language of life.
BioGeometry Announces a Cooperation Agreement with Aliyun to Jointly Explore the Global Digital Biology Market
Together, they aim to lead the digital biology industry’s ecosystem construction, making AI technology platforms more efficient and convenient to aid biopharmaceutical research and development.
BioGeometry Showcased AI-Driven Biologics Platform at Apsara Conference
BioGeometry as a rising star in AI-driven large molecule biomedicine and a partner of Aliyun in the healthcare and biopharmaceutical industry, was invited to participate the 2023 Apsara Conference.
Learn MoreBioGeometry Showcased AI-Driven Biologics Platform at Apsara Conference
